Boston Scientific Corporation (Boston Scientific) has plans to invest nearly EUR90 million in its manufacturing facility in Galway, Ireland. The investment decision, which is expected to generate 45 high-skilled, comes after the company acquisition of Labcoat, a startup firm that makes coatings for coronary stents. The investment is an effort to incorporate the facility in an earlier stage of its research and development process.
The investment by Boston Scientific, which is supported by IDA Ireland, was welcomed by Minister for Enterprise, Trade and Employment Mary Coughlan as “an enormous boost of confidence in Ireland’s RD&I (research, development and innovation) abilities.
Boston Scientific is medical devices company that develops, manufactures, and markets broad range of interventional medical specialties, including cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.